Indian biosimilar exports, presently valued at $0.8 billion, are expected to grow fivefold to $4.2 billion by 2030 and reach $30-35 billion by 2047 ...
Company has reported net profit after tax of Rs -14.36 Crore in latest quarter.The company’s top management includes Mrs.Sitaben S Patel, Mr.Sunil Bhandari, Mr.Mayurdwajsinh Sahadevsinh Rana, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback